COMMUNIQUÉS West-GlobeNewswire

Niger becomes the first country in sub-Saharan Africa to eliminate the transmission of onchocerciasis

30/01/2025 - 14:40

DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, commonly known as river [...]

Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics

30/01/2025 - 15:00

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics Orion Corporation [...]

PacBio Announces Appointment of Chris Smith to Board of Directors

30/01/2025 - 15:05

PacBio to leverage Chris' extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down. MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a [...]

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain

30/01/2025 - 15:25

PHOENIX, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company focused on regenerative medicine, today announced promising initial data from [...]

Leading Laser Medicine Expert Dr. Rox Anderson Joins AVAVA™ Board of Directors

30/01/2025 - 15:30

WALTHAM, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a leader in the aesthetic energy device market, proudly announces the appointment of Dr. Rox Anderson, co-founder of AVAVA, to its Board of Directors. Widely [...]

The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of Directors

30/01/2025 - 15:30

Dr. Blackman brings his singular experience as co-founder of Day One Biopharmaceuticals and a physician-scientist in pediatric neuro-oncology to the PBTF’s pediatric brain tumor community BOSTON, Jan. 30, 2025 (GLOBE [...]

SPR Announces Presentation of Four Abstracts Featuring the SPRINT® PNS System at NANS 2025

30/01/2025 - 16:28

CLEVELAND, Jan. 30, 2025 (GLOBE NEWSWIRE) -- SPR announces four featured abstracts that will be presented at the upcoming North American Neuromodulation Society (NANS) Annual Meeting in Orlando, January 29 – February 1 [...]

Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO®

30/01/2025 - 17:45

Saint Herblain (France), le 30 janvier 2025 – Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui la signature d’un nouveau contrat de $32.8 millions avec le [...]

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million

30/01/2025 - 17:45

Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) [...]

Saudi Hospitals Advance in Brand Finance’s 2025 Rankings

30/01/2025 - 18:00

RIYADH, Saudi Arabia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Saudi hospitals have made significant strides in the 2025 Brand Finance global ranking of the world’s Top 250 hospitals, with seven Saudi hospitals making the list [...]

Rakovina Therapeutics Announces Listing on Frankfurt Stock Exchange

30/01/2025 - 18:16

VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ( TSX-V: RKV ), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response [...]

60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

30/01/2025 - 20:20

WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced [...]

Regional Health Properties, Inc. Announces Distribution of Common Stock to Holders of its 12.5% Series B Cumulative Redeemable Preferred Shares

30/01/2025 - 21:35

Atlanta, GA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (NYSE American: RHE) (NYSE American: RHE-PA) announced today that its Board of Directors declared a dividend to the holders of [...]

Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

30/01/2025 - 21:45

A single oral dose of SYMBRAVO provided rapid migraine pain freedom and return to normal functioning within 2 hours, and sustained efficacy through 24 and 48 hours 85% and 77% of patients treated with a single dose of [...]

The Cooperative of American Physicians’ Mutual Protection Trust Earns Its 18th Consecutive AM Best A+ (Superior) Rating

30/01/2025 - 22:00

LOS ANGELES, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP) announced that AM Best has reaffirmed its A+ (Superior) rating for the Mutual Protection Trust (MPT). MPT provides [...]

Aclaris Therapeutics Announces Formation of New Scientific Advisory Board

30/01/2025 - 22:01

WAYNE, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]

PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

30/01/2025 - 22:05

DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. , dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to [...]

PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

30/01/2025 - 22:05

MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2024 financial results on Thursday, February 13, [...]

Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

30/01/2025 - 22:05

SAN DIEGO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to [...]